Schedule 13G ownership disclosure
VERTEX PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 92532F100
Event date: 2023-12-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 22,080,207
- Percent of class
- 8.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001422848-24-000255
- Form type
- SC 13G
- Filer
- Capital World Investors
- CIK
- CIK 1422849
- Filed
- Feb 09, 2024
- Reporting period
- Dec 29, 2023
- Description
- Schedule 13G beneficial ownership